Physician profile
Mark D Forman
NPI 1861488512
$21,056.56
in general payments reported to CMS, 2019-2025
23 companies · $1,337 in 2025
The $1,337 reported for 2025 was more than what 84% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $1,799 · 2021: $15K · 2022: $900 · 2023: $201 · 2024: $1,104 · 2025: $1,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,930 · Food and Beverage: $700 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,930.32 |
| Food and Beverage | $700.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16,368.10 | 2019-2025 | Jublia |
| Treace Medical Concepts, INC. | $3,283.67 | 2020-2025 | |
| Voom Medical Devices, INC. | $562.45 | 2025 | Revcon, Revcon Instrument Kit, Sterile |
| Cardiovascular Systems INC. | $145.60 | 2019 | |
| Smith+Nephew, INC. | $114.82 | 2019-2023 | Collagenase Santyl |
| Horizon Therapeutics Plc | $79.53 | 2019-2023 | Krystexxa |
| Stryker Corporation | $54.92 | 2025 | Easyfuse |
| Depuy Synthes Sales INC. | $50.83 | 2021-2025 | Motoband |
| Orthofix Medical, INC. | $49.09 | 2019-2023 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $43.89 | 2024 | A.L.P.S. |
| Impactortho, INC. | $37.47 | 2024 | |
| Djo, LLC | $32.15 | 2023 | Cmf |
| Bioventus LLC | $31.73 | 2019-2020 | |
| Averitas Pharma INC. | $26.21 | 2024 | Qutenza |
| Amgen INC. | $22.81 | 2025 | Krystexxa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22.32 | 2020 | |
| Celularity INC. | $22.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $21.87 | 2023 | Seglentis |
| Abbvie INC. | $21.35 | 2021 | |
| Globus Medical, INC. | $20.22 | 2025 | Senza |
| Aap Implants INC | $16.00 | 2021 | |
| Mayne Pharma Commercial LLC | $16.00 | 2021 | |
| Nevro Corp. | $13.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Forman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.